News

• TCT 2021 Will Take Place Online and In Person With Limited Attendance November 4-6, 2021 in Orlando, Florida
• Announcing TVT: The Structural Heart Summit
• A New Beat Offers Free Online Seminar Examining Disparities in Cardiovascular Care During Heart Month
• Heart Valve Collaboratory Announces U.S. Food and Drug Administration Participation in Collaborative Community
• CRF Offers Free Online Seminar to Help People Jump-Start their Heart Health During Heart Month
• CRF Fellows Course Connect Will Take Place Online May 7-9, 2021
• David J. Cohen, MD, MSc, Joins CRF as Director of Clinical and Outcomes Research and St. Francis Hospital as Director of Academic Affairs
• Free Access to TCT Connect Extended for One Year
• CTO 2021 Is Now an Online Event: CTO Connect
• Dr. Juan Granada Discusses COVID-19 and the Heart on ManoPod
• Randomized Clinical Trial Finds No Mortality Risk or Benefit Associated with Drug-Coated Devices in the Treatment of Peripheral Artery Disease
• Randomized Trial Reports Outcomes with Novel, Low Profile Fixed-Wire Drug-Eluting Stent that Facilitates Transradial Access
• Randomized Trial Comparing a Nano-Coated Coronary Stent and Shorter DAPT Did Not Meet Non-Inferiority Criteria for Thrombotic Events
• Randomized Trial Finds that Drug-Eluting Stents With Durable Polymers are Non-Inferior to Those With Biodegradable Polymers
• OnSight Medical Wins TCT Connect 2020 hark Tank Innovation Competition
• Deferral of PCI in FFR-Abnormal Lesions with Preserved Coronary Flow Reserve Is Not Associated with Similar Outcomes as Untreated Lesions with Normal FFR
• Physiology-guided Percutaneous Coronary Intervention Optimization Strategy May Lead to Improved Outcomes
• Fractional Flow Reserve Derived from Computed Tomography Coronary Angiography Did Not Significantly Reduce Costs But Reduced Rates of Invasive Coronary Angiography
• Trial Finds that Interventional Closure of Residual Atrial Septal Defect One-Month Post Transcatheter Mitral Valve Repair Was Not Superior to Medical Treatment
• Randomized Trial Studies Device Designed to Reduce Embolic Events in Patients Undergoing TAVR